|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
|
|---|---|---|---|---|
| ASSETS | ||||
| CURRENT ASSETS | ||||
| Cash and cash equivalents | ||||
| Accounts receivable | ||||
| Inventories | ||||
| Prepaid expenses and other current assets | ||||
| TOTAL CURRENT ASSETS | ||||
| NONCURRENT RESTRICTED CASH | ||||
| PATIENT EQUIPMENT, less accumulated depreciation of $366,126 and $356,888 as of December 31, 2021 and December 31, 2020, respectively | ||||
| PROPERTY, EQUIPMENT AND IMPROVEMENTS, NET | ||||
| INTANGIBLE ASSETS, NET | ||||
| OPERATING LEASE RIGHT-OF-USE ASSETS | ||||
| GOODWILL | ||||
| EQUITY METHOD INVESTMENT | ||||
| DEFERRED INCOME TAXES, NET | ||||
| NOTE RECEIVABLE, RELATED PARTY (Note 12) | ||||
| OTHER ASSETS | ||||
| TOTAL ASSETS | ||||
| LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) | ||||
| CURRENT LIABILITIES | ||||
| Accounts payable | ||||
| Accrued payroll and related taxes and benefits | ||||
| Other accrued liabilities | ||||
| Deferred revenue | ||||
| Current portion of operating lease liabilities | ||||
| Current portion of long-term debt | ||||
| TOTAL CURRENT LIABILITIES | ||||
| LONG-TERM DEBT, less current portion | ||||
| OPERATING LEASE LIABILITIES, less current portion | ||||
| DEFERRED INCOME TAXES, NET | ||||
| OTHER NONCURRENT LIABILITIES | ||||
| TOTAL LIABILITIES | ||||
| STOCKHOLDERS' EQUITY (DEFICIT) | ||||
| Common stock, $0.01 par value: 1,000,000,000 authorized; 35,521,594 and 35,210,915 shares issued and outstanding as of December 31, 2021 and February 10, 2021, respectively (Note 1) | ||||
| Additional paid-in capital | ||||
| Accumulated deficit | ||||
| TOTAL STOCKHOLDERS' EQUITY (DEFICIT) | ||||
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) |
Loading...
